Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burnham

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Alzheimer'S Research & Therapy|April 9, 2022
Mesial temporal tau in amyloid-β-negative cognitively normal older personsNatasha Krishnadas, Vincent Doré, Colin Groot, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 2, 2025
Clinical validation of the Lilly SP-X P-tau217 assay: Performance in underrepresented cohortsMichael E Hodsdon, Adam Abel, Antonio Chambers, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathologySamantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Brain Communications|September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brainSamantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
The Journal of Prevention of Alzheimer'S Disease|November 6, 2019
Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL StudyS C Burnham, P M Coloma, Q-X Li, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission TomographyBelinda M Brown, Stephanie R Rainey-Smith, Vincent Dore, et al.
Neuroimage|August 2, 2022
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3Pierrick Bourgeat, Vincent Doré, Samantha C Burnham, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Alzheimer'S Research & Therapy|April 9, 2022
Mesial temporal tau in amyloid-β-negative cognitively normal older personsNatasha Krishnadas, Vincent Doré, Colin Groot, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 2, 2025
Clinical validation of the Lilly SP-X P-tau217 assay: Performance in underrepresented cohortsMichael E Hodsdon, Adam Abel, Antonio Chambers, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathologySamantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Brain Communications|September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brainSamantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
The Journal of Prevention of Alzheimer'S Disease|November 6, 2019
Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL StudyS C Burnham, P M Coloma, Q-X Li, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission TomographyBelinda M Brown, Stephanie R Rainey-Smith, Vincent Dore, et al.
Neuroimage|August 2, 2022
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3Pierrick Bourgeat, Vincent Doré, Samantha C Burnham, et al.
Pageof 11